XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating activities    
Net income $ 36,590 $ 53,632
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization of property, equipment and internal-use software 27,587 28,399
Amortization of intangible assets 12,945 12,181
Provision for uncollectible overdrawn accounts from purchase transactions 5,529 7,407
Provision for loan losses 15,731 18,452
Stock-based compensation 19,798 20,493
Losses in equity method investments 7,611 6,647
Amortization of discount on available-for-sale investment securities (1,129) (544)
Impairment of long-lived assets 0 4,134
Other (2,293) (1,445)
Changes in operating assets and liabilities:    
Accounts receivable, net 7,799 5,614
Prepaid expenses and other assets 16,023 15,809
Deferred expenses 12,755 9,562
Accounts payable and other accrued liabilities (14,993) 12,046
Deferred revenue (17,466) (14,192)
Income tax receivable/payable 1,706 11,968
Other, net (427) (2,709)
Net cash provided by operating activities 127,766 187,454
Investing activities    
Purchases of available-for-sale investment securities 0 (694,358)
Proceeds from maturities of available-for-sale securities 82,221 165,635
Proceeds from sales and calls of available-for-sale securities 56 2,875
Payments for acquisition of property and equipment (38,120) (36,537)
Net changes in loans (17,866) (18,732)
Investment in TailFin Labs, LLC (35,000) (35,000)
Purchases of other investments 0 (31,934)
Other investing activities (872) (1,448)
Net cash used in investing activities (9,581) (649,499)
Financing activities    
Borrowings on revolving line of credit 83,000 50,000
Repayments on revolving line of credit (118,000) (50,000)
Proceeds from exercise of options and ESPP purchases 3,415 3,415
Taxes paid related to net share settlement of equity awards (2,976) (4,016)
Net changes in deposits (216,312) 85,240
Net changes in settlement assets and obligations to customers (21,705) (120,063)
Contingent consideration payments 0 (1,647)
Repurchase of Class A common stock 0 (44,046)
Net cash used in financing activities (272,578) (81,117)
Net decrease in unrestricted cash, cash equivalents and restricted cash (154,393) (543,162)
Unrestricted cash, cash equivalents and restricted cash, beginning of period 819,845 1,325,640
Unrestricted cash, cash equivalents and restricted cash, end of period 665,452 782,478
Cash paid for interest 2,721 326
Cash paid for income taxes 9,289 4,086
Unrestricted cash and cash equivalents 661,452 776,305
Restricted cash 4,000 6,173
Total unrestricted cash, cash equivalents and restricted cash, end of period $ 665,452 $ 782,478